| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 251.79B | 251.53B | 240.50B | 242.06B | 234.85B | 227.94B |
| Gross Profit | 62.24B | 55.91B | 51.83B | 50.54B | 52.07B | 52.89B |
| EBITDA | 15.69B | 14.18B | 12.95B | 12.74B | 13.87B | 13.63B |
| Net Income | 6.68B | 5.87B | 5.25B | 6.10B | 5.68B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 221.12B | 218.34B | 202.28B | 189.27B | 188.42B | 187.48B |
| Cash, Cash Equivalents and Short-Term Investments | 25.98B | 31.88B | 26.40B | 22.97B | 24.19B | 24.75B |
| Total Debt | 67.61B | 61.65B | 55.64B | 54.23B | 53.65B | 58.60B |
| Total Liabilities | 124.79B | 124.77B | 116.66B | 110.62B | 115.06B | 120.78B |
| Stockholders Equity | 94.37B | 91.72B | 83.98B | 77.18B | 72.01B | 65.43B |
Cash Flow | ||||||
| Free Cash Flow | 2.55B | 6.89B | 4.37B | 98.00M | 5.14B | 10.47B |
| Operating Cash Flow | 15.48B | 16.16B | 14.24B | 5.76B | 9.93B | 15.82B |
| Investing Cash Flow | -14.85B | -12.43B | -10.33B | -5.62B | -3.86B | -4.40B |
| Financing Cash Flow | 671.00M | 1.75B | -431.00M | -1.37B | -6.52B | -8.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥45.09B | 16.86 | ― | 3.48% | 18.42% | 51.06% | |
77 Outperform | ¥63.79B | 11.67 | 16.91% | 2.28% | 12.37% | 26.48% | |
74 Outperform | ¥66.59B | 9.41 | ― | 1.52% | 5.75% | 59.69% | |
73 Outperform | ¥111.36B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
68 Neutral | ¥109.35B | 9.91 | ― | 2.91% | 31.48% | 83.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥70.65B | 12.01 | ― | 2.91% | 5.82% | 21.40% |